Print Friendly, PDF & Email

NCT/Study#

NA /

AT148002

A Phase 1/2 Study Of Alx148 In Combination With Azacitidine In Patients With Higher Risk Mds

DISEASE GROUP:

Leukemia

current phase:

Phase I/II

STUDY STATUS:

Active

Location:

Hackensack, NJ

For More information:

Call 201-518-3587